…
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. The company also exports its products. SOHM, Inc. was founded in 2005 and is based in Corona, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Sohm Inc. is an OTC Pink-listed company whose core business and operations are not well documented in publicly available filings. Because of limited disclosure, major long-term growth drivers cannot be reliably identified, though speculative investors may monitor future filings for clarification.
Primary risks include limited disclosure, extremely low trading liquidity, high dilution and volatility risk, and operational or financial opacity that could materially affect value.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
| Income before tax | -1.02M | -1.13M | -0.55M | -0.98M | -0.57M |
| Minority interest | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income | -1.02M | -1.13M | -0.55M | -0.98M | -0.57M |
| Selling general administrative | 1.12M | 1.35M | 1.06M | 1.28M | 0.72M |
| Gross profit | 0.50M | 0.33M | 0.54M | 0.30M | 0.16M |
| Ebit | -0.82M | -1.13M | -0.55M | -0.98M | -0.57M |
| Non operating income net other | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Operating income | -0.82M | -1.13M | -0.55M | -0.98M | -0.57M |
| Other operating expenses | 0.20M | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Extraordinary items | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Non recurring | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Other items | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Income tax expense | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total revenue | 1.96M | 1.30M | 1.34M | 0.78M | 0.19M |
| Total operating expenses | 0.00M | 2.43M | 1.89M | 1.76M | 0.76M |
| Cost of revenue | 1.46M | 0.96M | 0.80M | 0.48M | 0.04M |
| Total other income expense net | - | 0.00M | 0.00M | 0.00M | -0.00M |
| Discontinued operations | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Net income from continuing ops | -1.02M | -1.13M | -0.55M | -0.98M | -0.57M |
| Net income applicable to common shares | -1.02M | -1.13M | -0.55M | -0.98M | -0.57M |
| Preferred stock and other adjustments | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
| Total assets | 2.91M | 3.18M | 2.53M | 0.68M | 0.38M |
| Intangible assets | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Other current assets | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Total liab | 4.64M | 3.88M | 2.09M | 0.71M | 0.60M |
| Total stockholder equity | -1.73M | -0.70M | 0.44M | -0.02M | -0.21M |
| Deferred long term liab | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Other current liab | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Common stock | 3.25M | 3.25M | 3.07M | 2.06M | 0.89M |
| Retained earnings | -4.98M | -3.95M | -2.63M | -2.08M | -1.10M |
| Other liab | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Good will | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Other assets | - | 0.00M | 0.00M | 0.00M | 0.01M |
| Cash | 0.01M | 0.18M | 0.13M | 0.16M | 0.11M |
| Total current liabilities | 1.14M | 1.07M | 0.53M | 0.54M | 0.06M |
| Short term debt | 0.90M | 0.00M | 0.00M | 0.00M | 0.00M |
| Short long term debt | 0.90M | 0.00M | 0.00M | 0.00M | 0.00M |
| Other stockholder equity | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Property plant equipment | 1.68M | 1.88M | 0.55M | 0.10M | 0.01M |
| Total current assets | 1.23M | 1.30M | 1.98M | 0.58M | 0.36M |
| Long term investments | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Net tangible assets | -1.73M | -0.70M | 0.44M | -0.02M | -0.21M |
| Short term investments | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Net receivables | 0.80M | 0.95M | 1.73M | 0.37M | 0.25M |
| Long term debt | 3.50M | 2.81M | 1.56M | 0.17M | 0.54M |
| Inventory | 0.42M | 0.17M | 0.12M | 0.05M | 0.00M |
| Accounts payable | 0.24M | 0.96M | 0.24M | 0.07M | 0.00M |
| Total permanent equity | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Noncontrolling interest in consolidated entity | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Temporary equity redeemable noncontrolling interests | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Accumulated other comprehensive income | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Additional paid in capital | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Common stock total equity | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Preferred stock total equity | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings total equity | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Treasury stock | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Accumulated amortization | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Non currrent assets other | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Deferred long term asset charges | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Non current assets total | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Capital lease obligations | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Long term debt total | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 |
| Investments | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to liabilities | 0.07M | 0.72M | 0.18M | 0.07M | -0.02M |
| Total cashflows from investing activities | -0.00M | -1.45M | -0.49M | -0.08M | -0.08M |
| Net borrowings | 0.68M | 1.26M | 1.39M | -0.37M | -0.01M |
| Total cash from financing activities | 0.68M | 1.43M | 2.40M | 0.80M | 0.76M |
| Change to operating activities | - | 0.69M | -1.42M | 0.33M | -0.08M |
| Net income | -1.02M | -1.13M | -0.55M | -0.98M | -0.57M |
| Change in cash | -0.17M | 0.06M | -0.03M | 0.05M | 0.10M |
| Total cash from operating activities | -0.85M | 0.07M | -1.95M | -0.67M | -0.66M |
| Depreciation | 0.20M | 0.12M | 0.03M | 0.00M | 0.00M |
| Other cashflows from investing activities | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Dividends paid | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to inventory | -0.25M | -0.05M | -0.07M | -0.05M | -0.05M |
| Change to account receivables | 0.15M | -0.09M | -0.12M | -0.04M | 0.01M |
| Sale purchase of stock | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Other cashflows from financing activities | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Change to netincome | - | -0.19M | 0.00M | 0.01M | 0.01M |
| Capital expenditures | 0.00M | 1.45M | 0.49M | 0.08M | 0.08M |
| Change receivables | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash flows other operating | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Exchange rate changes | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Cash and cash equivalents changes | - | 0.00M | 0.00M | 0.00M | 0.00M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| SHMN Sohm Inc. |
- -% |
0.00 | - | - | 0.83 | - |
| MKKGY Merck KGaA ADR |
-0.68 2.09% |
31.83 | 21.25 | 14.93 | 3.10 | 2.14 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
163.45 | 24.86 | 15.11 | 3.13 | 1.98 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.38 1.77% |
21.79 | - | 10.96 | 0.01 | 1.20 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.05 | - | 10.66 | 0.01 | 1.16 |
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. It offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. The company also exports its products. SOHM, Inc. was founded in 2005 and is based in Corona, California.
| Name | Title | Year Born |
|---|---|---|
| Mr. Shailesh Shah | Chairman, CEO, Pres, CEO of US, India & Global Ops and Pres of US, India & Global Ops | 1966 |
| Ms. Swati Shah | VP, Sec., Treasurer and Director | NA |
| Mr. Sanjiv Bosamia | Chief Exec. Officer of Dermatology and Cosmeceutical Division | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.